Drawing for CURAE PHARMA360

USPTO serial 97307620

CURAE PHARMA360

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
FURDA, MICHAEL
Law office
—

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CURAE PHARMA360?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cecily Anne O'Regan

Cecily Anne O'Regan Fishman Stewart PLLC800 Tower Ave., Suite 610Troy, MI 48098United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products for the treatment of cancerACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 5, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 5, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 20, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 20, 2024EX1GSOU EXTENSION 1 GRANTED—
Nov 20, 2024AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 15, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 15, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 15, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 15, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 15, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 2, 2024EXT1SOU EXTENSION 1 FILED—
Oct 2, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 2, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 28, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 28, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 28, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 6, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 6, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 17, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 2, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 24, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 24, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 24, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 3, 2023RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Feb 8, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 8, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 8, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 3, 2023GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jan 3, 2023GNSLLETTER OF SUSPENSION E-MAILED—
Jan 3, 2023CNSLSUSPENSION LETTER WRITTEN—
Dec 22, 2022DOCKASSIGNED TO EXAMINER—
Mar 16, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 15, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance